Equities

Pulsion Medical Systems SE

PUS:MUN

Pulsion Medical Systems SE

Actions
Health CareMedical Equipment and Services
  • Price (EUR)16.60
  • Today's Change0.00 / 0.00%
  • Shares traded100.00
  • 1 Year change-5.14%
  • Beta0.0643
Data delayed at least 15 minutes, as of Sep 20 2024 07:02 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Pulsion Medical Systems SE had net income fall -30.00% from 7.19m to 5.03m despite a 20.69% increase in revenues from 29.66m to 35.80m. An increase in the cost of goods sold as a percentage of sales from 48.48% to 65.35% was a component in the falling net income despite rising revenues.
Gross margin63.66%
Net profit margin17.07%
Operating margin23.23%
Return on assets16.58%
Return on equity21.55%
Return on investment21.24%
More ▼

Cash flow in EURView more

SmartText is unavailable
Cash flow per share0.8244
Price/Cash flow per share20.13
Book value per share3.36
Tangible book value per share3.20
More ▼

Growth rates in EUR

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -399.22%. Additionally, five year annualized dividend per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)4.59%
Div growth rate (5 year)0.00%
Payout ratio (TTM)0.00%
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.